These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31970413)

  • 21. Comparison of endocannabinoids levels, FAAH gene polymorphisms, and appetite regulatory substances in women with and without binge eating disorder: a cross- sectional study.
    Yagin NL; Aliasgari F; Alizadeh M; Aliasgharzadeh S; Mahdavi R
    Nutr Res; 2020 Nov; 83():86-93. PubMed ID: 33038759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.
    Knani I; Earley BJ; Udi S; Nemirovski A; Hadar R; Gammal A; Cinar R; Hirsch HJ; Pollak Y; Gross I; Eldar-Geva T; Reyes-Capo DP; Han JC; Haqq AM; Gross-Tsur V; Wevrick R; Tam J
    Mol Metab; 2016 Dec; 5(12):1187-1199. PubMed ID: 27900261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors.
    Yi B; Nichiporuk I; Nicolas M; Schneider S; Feuerecker M; Vassilieva G; Thieme D; Schelling G; Choukèr A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():92-7. PubMed ID: 26780604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: A prospective observational study.
    Al-Rawi N; Madkour M; Jahrami H; Salahat D; Alhasan F; BaHammam A; Al-Islam Faris M
    PLoS One; 2020; 15(8):e0237922. PubMed ID: 32845924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD.
    Crombie KM; Leitzelar BN; Brellenthin AG; Hillard CJ; Koltyn KF
    Biol Psychol; 2019 Jul; 145():1-7. PubMed ID: 30978371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children.
    Klein KO; Larmore KA; de Lancey E; Brown JM; Considine RV; Hassink SG
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3469-75. PubMed ID: 9768648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome.
    Jehle J; Goerich H; Bindila L; Lutz B; Nickenig G; Tiyerili V
    PLoS One; 2019; 14(12):e0227142. PubMed ID: 31887202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder.
    Crombie KM; Brellenthin AG; Hillard CJ; Koltyn KF
    J Trauma Stress; 2018 Feb; 31(1):134-145. PubMed ID: 29388710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
    Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
    PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
    Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
    Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis.
    Carter GT; McLaughlin RJ; Cuttler C; Sauber GJ; Weeks DL; Hillard CJ; Weiss MD
    Muscle Nerve; 2021 Jan; 63(1):120-126. PubMed ID: 33094490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between serum leptin levels and 24-hour blood pressure in obese women.
    Guagnano MT; Manigrasso MR; Ballone E; Della Vecchia R; Riccioni G; Marinopiccoli M; Nutini M; Sensi S; Davì G
    Obes Res; 2003 Apr; 11(4):549-55. PubMed ID: 12690084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels.
    Brellenthin AG; Crombie KM; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2017 Aug; 49(8):1688-1696. PubMed ID: 28319590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans.
    Fagundo AB; de la Torre R; Jiménez-Murcia S; Agüera Z; Pastor A; Casanueva FF; Granero R; Baños R; Botella C; Del Pino-Gutierrez A; Fernández-Real JM; Fernández-García JC; Frühbeck G; Gómez-Ambrosi J; Menchón JM; Moragrega I; Rodríguez R; Tárrega S; Tinahones FJ; Fernández-Aranda F
    PLoS One; 2013; 8(6):e66387. PubMed ID: 23840456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
    Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
    Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease.
    Zelber-Sagi S; Azar S; Nemirovski A; Webb M; Halpern Z; Shibolet O; Tam J
    Obesity (Silver Spring); 2017 Jan; 25(1):94-101. PubMed ID: 27863097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circadian variation of serum leptin in healthy and diabetic men.
    Kanabrocki EL; Hermida RC; Wright M; Young RM; Bremner FW; Third JL; Ryan MD; Ayala DE; Johnson M; Nemchausky BA; Shirazi P; Scheving LE; Olwin JH
    Chronobiol Int; 2001 Mar; 18(2):273-83. PubMed ID: 11379667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation.
    Quercioli A; Pataky Z; Montecucco F; Carballo S; Thomas A; Staub C; Di Marzo V; Vincenti G; Ambrosio G; Ratib O; Golay A; Mach F; Harsch E; Schindler TH
    JACC Cardiovasc Imaging; 2012 Aug; 5(8):805-15. PubMed ID: 22897994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for disruption of normal circadian cortisol rhythm in women with obesity.
    Al-Safi ZA; Polotsky A; Chosich J; Roth L; Allshouse AA; Bradford AP; Santoro N
    Gynecol Endocrinol; 2018 Apr; 34(4):336-340. PubMed ID: 29068243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.